The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application

Kanuni Sultan Suleyman Training and Research Hospital

Status: Completed

Conditions: Contraception; Pain; IUD

Treatments: Other: with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )

Study type: Observational

Funder types: Other

Identifiers

NCT04379102

ntria

Details and patient eligibility

About

Patients who visited our family planning clinic and opted for IUD application for contraception purposes were also offered NT/TLA treatments simultaneously. 40 patients who matched the inclusion criteria and received IUDs and NT/TLA treatments were included in the study group and 41 patients who only received IUDs were included in the control group. All patients received copper IUDs and none of them were on additional hormonal treatment. Before the insertion of IUD, women in the therapy group received NT treatment with 6ml of 1% procaine injected transvaginal into the cervix at 5 and 7 o'clock localizations. Following IUD insertion, another 6ml of 1% procaine was injected into the Frankenhauser ganglia bilaterally. A final dose of 8ml of 1% procaine was injected into the abdominal trigger points and intracutaneously into the L4-S4 dermatomes as quaddles.

Enrollment: 80 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• not pregnant women
• healty women age between 18- 45 years old

Exclusion criteria

• chronic diseases which could cause chronic pelvic pain such as endometriosis
• which makes them prone to infections such as diabetes mellitus
• complication had arised during the IUD insertion, such as uterine perforation

Trial design

80 participants in 1 patient group

IUD patients

Description:

80 patients who matched the inclusion criteria and received IUDs

Treatment:

Other: with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )